drug resistance chemotherapy rapidly emerging resistance drug carries resistance unrelated anticancer drugs leading multidrug resistance mdr major factor mdr pgp mediated abc transport eukaryotic cells acts drug emux pump mdr1 gene involved NUMBER protein production localized human chromosome NUMBER band p2 point mutations patterns variety stimuli increase expression mdr1 gene lowered extracellular ph heat shock arsenite cytotoxic agents anticancer drugs transfection oncogenes alternative hypothesis efflux pump claims modifies intracellular environment reduce accumulation anticancer drugs cancer cells creating ionic proton gradients chemosensitizers block drug extrusion generally physiological ph possess basic nitrogen atom rings blocking does depend drug chirality opens way treating related mdr chiral versions drugs relatively harmless terms believe resistance modifiers combined cytostatics chemotherapeutically effective cancer patients references NUMBER p glycoprotein p gp p gp NUMBER NUMBER cross resistance hiv uv irradiation p gp p gp lipid soluble planar p gp p gp effects